Synthesis and distribution of opioid and related peptides. Period of performance: 02/15/2022-02/14/2027. N01DA-22-8963.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95022D00005
- Awardee
-
Polypeptide Laboratories San Diego, LLC UEI KULKXN9J6PF9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $1,711,777 obligated
Award facts
- Combined order value
- $1,711,777 Current and potential, with all options
- Last date to order 94% complete
- IDV ceiling 62% used
- $2,781,317.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract (IDC) to Polypeptide Laboratories San Diego, LLC (doing business as Polypeptide Labs) in February 2022. The $2,781,317 contract covers the synthesis and distribution of opioid and related peptides over a 5-year period of performance from February 15, 2022 to February 14, 2027. Polypeptide Labs, a specialized manufacturer of pharmaceutical-grade peptides, will leverage its expertise to deliver these critical compounds to support NIDA's biomedical research efforts aimed at addressing substance abuse disorders.
Under this IDC, NIDA has issued multiple firm fixed price and cost plus fixed fee delivery orders to Polypeptide Labs, valued at $598,190 and $518,493 respectively, for one-year periods of performance. These task orders specify the synthesis and distribution of opioid and related peptides from the contractor's facilities in San Diego, California. The IDC was awarded without any set-asides, demonstrating Polypeptide Labs' qualifications and ability to meet NIDA's specialized peptide requirements in support of its broader research initiatives into addiction treatment and prevention.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $586,469 |
Quick answers
Who was awarded contract 75N95022D00005?
75N95022D00005 was awarded to Polypeptide Laboratories San Diego, LLC by National Institute on Drug Abuse (National Institutes of Health) on February 15, 2022.
How much is contract 75N95022D00005 worth?
Orders under 75N95022D00005 have obligated $1,711,777. 75N95022D00005's own ceiling is $2,781,317.
How many orders have been placed under contract 75N95022D00005?
3 orders have been placed under 75N95022D00005, the latest on February 15, 2025.
Who can order from contract 75N95022D00005?
75N95022D00005 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95022D00005 competed?
The extent of competition for 75N95022D00005 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV